VISCO360 Viscosurgical System given EU CE mark approval for use in glaucoma- Sight Sciences

Sight Sciences has announced that CE mark approval has been given for the VISCO360 Viscosurgical System for use in glaucoma and this system will be presented during the European Society of Cataract and Refractive Surgeons (ESCRS). The VISCO360 Viscosurgical System is commercially available in the United States as a manual surgical tool but is investigational in the United States for the specific indication of IOP reduction in adult, pseudophakic patients with primary open angle glaucoma.

The VISCO360 System is a fully integrated, single-handed, single-use device specifically designed for an ab interno approach using one single clear corneal incision. The system combines a custom access cannula, a soft and flexible microcatheter with an atraumatic tip, an internal infusion pump and viscoelastic reservoir, and a wheel that controls advancement and retraction of the microcatheter using only a single finger. The VISCO360 System now offers ophthalmologists in the EU a user friendly, clear corneal approach to canaloplasty, a glaucoma procedure.